Designing temporal- and spatial-control multifunctional nanoformulations for synergistic photodynamic–enhanced tumour immunotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer Immunotherapy and Biomarkers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Molecular mechanisms of astragaloside‑IV in cancer therapy (review)10.3892/ijmm.2021.4846 ↗
2. Immunostimulatory effects of polysaccharides from spirulina platensis in vivo and vitro and their activation mechanism on RAW246.7 macrophages10.3390/md18110538 ↗
3. Biocompatible astaxanthin as a novel marine-oriented agent for dual chemo-photothermal therapy10.1371/journal.pone.0174687 ↗
4. Using C-doped TiO2 nanoparticles as a novel sonosensitizer for cancer treatment10.3390/antiox9090880 ↗
5. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer10.1016/j.jtho.2020.06.014 ↗
6. Risk of ischemic heart disease in women after radiotherapy for breast cancer10.1056/NEJMoa1209825 ↗
7. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer10.1200/JCO.2016.71.6142 ↗
8. pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy10.3390/pharmaceutics12111078 ↗
9. Advances in management of bladder cancer-the role of photodynamic therapy10.3390/molecules27030731 ↗
10. Reactive oxygen species-related nanoparticle toxicity in the biomedical field10.1186/s11671-020-03344-7 ↗
11. Cascade-responsive nanobomb with domino effect for anti-tumor synergistic therapies10.1093/nsr/nwab139 ↗
12. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy10.1016/j.biomaterials.2022.121433 ↗
13. Construction of multicolor upconversion nanotheranostic agent for in-situ cooperative photodynamic therapy for deep-seated malignant tumors10.3389/fchem.2020.00052 ↗
14. A photoactivatable antibody–Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy10.1088/1748-605X/ab9f57 ↗
15. Human and mouse PD-L1: similar molecular structure, but different druggability profiles10.1016/j.isci.2020.101960 ↗
16. Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia10.1186/s12943-018-0805-1 ↗
17. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis10.1016/j.jconrel.2013.08.021 ↗
18. PD-1/PD-L1 checkpoint inhibitors in tumor immunotherapy
19. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy10.1038/s41467-021-20893-2 ↗
20. In situ antitumor vaccination: targeting the tumor microenvironment10.1002/jcp.29551 ↗
21. The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy10.1038/s41423-021-00786-6 ↗
22. Elements of cancer immunity and the cancer-immune set point10.1038/nature21349 ↗
23. Targeting and specific activation of antigen-presenting cells by endogenous antigen-loaded nanoparticles elicits tumor-specific immunity10.1002/advs.201900069 ↗
24. CAR T cell therapy for solid tumors10.1146/annurev-med-062315-120245 ↗
25. Phthalocyanines as medicinal photosensitizers: developments in the last five years10.1016/j.ccr.2017.08.003 ↗
26. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells10.1371/journal.pone.0105778 ↗
27. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy10.1096/fj.05-4305fje ↗
28. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway10.1186/s12951-021-00919-z ↗
29. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy10.1126/sciadv.aay1357 ↗
30. Nanomaterials innovation as an enabler for effective cancer interventions10.1016/j.biomaterials.2020.119926 ↗
31. Engineering synthetic vaccines using cues from natural immunity10.1038/nmat3775 ↗
32. Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review10.1186/s12935-021-01946-4 ↗
33. Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy10.1007/s40005-017-0377-x ↗
34. Perspectives on the role of photodynamic therapy in the treatment of pancreatic cancer
35. Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect10.1021/acsnano.8b04371 ↗
36. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming10.1016/j.intimp.2021.108164 ↗
37. PDT-induced inflammatory and host responses10.1039/c0pp00308e ↗
38. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy10.1038/ncomms12499 ↗
39. Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy10.1021/jacs.6b06663 ↗
40. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer10.1038/s41598-021-81465-4 ↗
41. Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress10.1007/s13277-015-3797-0 ↗
42. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model10.1073/pnas.0709256105 ↗
43. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
44. A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy10.1039/C9TB02482D ↗
45. Three birds with one stone: A ferric pyrophosphate based nanoagent for synergetic NIR-triggered photo/chemodynamic therapy with glutathione depletion10.1016/j.cej.2019.122369 ↗
46. Type I photosensitizers revitalizing photodynamic oncotherapy
47. Development of a hydrogen peroxide-responsive and oxygen-carrying nanoemulsion for photodynamic therapy against hypoxic tumors using phase inversion composition method10.1142/S1793545821500036 ↗
48. MnO2 nanosheets anchored with polypyrrole nanoparticles as a multifunctional platform for combined photothermal/photodynamic therapy of tumors10.1039/D1FO00032B ↗
49. Self-supplying O2 through the catalase-like activity of gold nanoclusters for photodynamic therapy against hypoxic cancer cells
50. Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with insitu oxygen generation ability10.1016/j.apsb.2020.05.003 ↗
51. Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2O2-responsive O2-evolving synergetic cancer therapy10.1002/adma.201704833 ↗
52. Multifunctional MnO2/Ag3SbS3 nanotheranostic agent for single-laser-triggered tumor synergistic therapy in the NIR-II biowindow10.1021/acsami.1c21752 ↗
53. Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy10.1021/acsnano.9b09426 ↗
54. Dual-stage light amplified photodynamic therapy against hypoxic tumor based on an O2 self-sufficient nanoplatform10.1002/smll.201701621 ↗
55. H2O2-responsive gold nanoclusters @ mesoporous silica @ manganese dioxide nanozyme for “Off/On” modulation and enhancement of magnetic resonance imaging and photodynamic therapy10.1021/acsami.1c00430 ↗
56. Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer10.1021/acs.nanolett.8b02720 ↗
57. Manganese-based nanozymes: multienzyme redox activity and effect on the nitric oxide produced by endothelial nitric oxide synthase10.1002/chem.201800770 ↗
58. Rapid decomposition and catalytic cascade nanoplatforms based on enzymes and Mn-etched dendritic mesoporous silicon for MRI-guided synergistic therapy10.1021/acsami.0c12580 ↗
59. Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy10.1021/jacs.8b01072 ↗
60. Defect dominated hierarchical Ti‐metal‐organic frameworks via a linker competitive coordination strategy for toluene removal10.1002/adfm.202102511 ↗
61. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases10.1016/j.biomaterials.2018.05.051 ↗
62. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer10.1016/j.actbio.2020.01.012 ↗
63. Graphene-based smart platforms for combined cancer therapy10.1002/adma.201800662 ↗
64. Dual Fenton catalytic nanoreactor for integrative Type-I and Type-II photodynamic therapy against hypoxic cancer cells10.1021/acsabm.9b00456 ↗
65. A black phosphorus/manganese dioxide nanoplatform: oxygen self-supply monitoring, photodynamic therapy enhancement and feedback10.1016/j.biomaterials.2018.10.018 ↗
66. Nanoceria decorated flower-like molybdenum sulphide nanoflakes: an efficient nanozyme for tumour selective ROS generation and photo thermal therapy10.1039/C9CC03763B ↗
67. Cu2MoS4/Au heterostructures with enhanced catalase-like activity and photoconversion efficiency for primary/metastatic tumors eradication by phototherapy-induced immunotherapy10.1002/smll.201907146 ↗
68. Near-infrared triggered Ti3C2/g-C3N4 heterostructure for mitochondria-targeting multimode photodynamic therapy combined photothermal therapy10.1016/j.nantod.2020.100919 ↗
69. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer10.1016/j.pdpdt.2017.05.015 ↗
70. The mechanism of stimulating and mobilizing the immune system enhancing the anti-tumor immunity
71. Nanoparticle delivery of immunostimulatory agents for cancer immunotherapy10.7150/thno.37216 ↗
72. Construction of near infrared light triggered nanodumbbell for cancer photodynamic therapy10.1016/j.jcis.2017.01.053 ↗
73. Potential of dual drug delivery systems: MOF as hybrid nanocarrier for dual drug delivery in cancer treatment10.1002/slct.202201288 ↗
74. Photodynamic therapy combined with antihypoxic signaling and CpG adjuvant as an in situ tumor vaccine based on metal-organic framework nanoparticles to boost cancer immunotherapy10.1002/adhm.201900996 ↗
75. Polymeric nanoparticles with ROS-responsive prodrug and platinum nanozyme for enhanced chemophotodynamic therapy of colon cancer10.1002/advs.202001853 ↗
76. Light-responsive, singlet-oxygen-triggered on-demand drug release from photosensitizer-doped mesoporous silica nanorods for cancer combination therapy10.1002/adfm.201600722 ↗
77. CpG ODN1826 as a promising Mucin1-maltose-binding protein vaccine adjuvant induced DC maturation and enhanced antitumor immunity10.3390/ijms19030920 ↗
78. A nanoscale metal-organic framework to mediate photodynamic therapy and deliver CpG oligodeoxynucleotides to enhance antigen presentation and cancer immunotherapy10.1002/anie.201911429 ↗
79. Simultaneous delivery of DNA vaccine and hydrophobic adjuvant using reducible polyethylenimine-functionalized graphene oxide for activation of dendritic cells10.1016/j.jiec.2019.08.038 ↗
80. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes10.1080/10717544.2022.2044937 ↗
81. Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockade10.1038/s41416-020-0757-2 ↗
82. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response10.1016/j.apsb.2021.03.014 ↗
83. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer10.1002/jbio.201300072 ↗
84. Nanoscale metal-organic frameworks for therapeutic, imaging, and sensing applications10.1002/adma.201707634 ↗
85. Nanostructured metal–organic frameworks and their bio-related applications10.1016/j.ccr.2015.08.008 ↗
86. NIR/ROS‐responsive black phosphorus QD vesicles as immunoadjuvant carrier for specific cancer photodynamic immunotherapy
87. Multi-shelled dendritic mesoporous organosilica hollow spheres: roles of composition and architecture in cancer immunotherapy10.1002/anie.201701550 ↗
88. Local phototherapy synergizes with immunoadjuvant for treatment of pancreatic cancer through induced immunogenic tumor vaccine10.1158/1078-0432.CCR-18-1126 ↗
89. PEGylated reduced-graphene oxide hybridized with Fe3O4 nanoparticles for cancer photothermal-immunotherapy10.1039/C9TB00630C ↗
90. Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy10.1002/adma.201802479 ↗
91. Degradable carbon-silica nanocomposite with immunoadjuvant property for dual-modality photothermal/photodynamic therapy10.1021/acsnano.9b06168 ↗
92. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics10.2217/nnm-2017-0208 ↗
93. Photodynamic therapy and anti-tumor immunity10.1002/lsm.20362 ↗
94. Photodynamic therapy of cancer: an update
95. Photodynamic-therapy activates immune response by disrupting immunity homeostasis of tumor cells, which generates vaccine for cancer therapy10.7150/ijbs.12852 ↗
96. Artificial metalloprotein nanoanalogues: in situ catalytic production of oxygen to enhance photoimmunotherapeutic inhibition of primary and abscopal tumor growth
97. Engineering antigen as photosensitiser nanocarrier to facilitate ROS triggered immune cascade for photodynamic immunotherapy10.1016/j.biomaterials.2020.119964 ↗
98. Highly efficient cascading synergy of cancer photo-immunotherapy enabled by engineered graphene quantum dots/photosensitizer/CpG oligonucleotides hybrid nanotheranostics10.1016/j.biomaterials.2019.03.020 ↗
99. Tumour-intrinsic resistance to immune checkpoint blockade10.1038/s41577-019-0218-4 ↗
100. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy